Tag: rare disease

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...

Novelion Therapeutics Reports First Quarter 2018 Financial Results

Novelion Therapeutics (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases, today reported...

Shire: 1st Quarter Results

Shire (LSE: SHP, NASDAQ: SHPG), the leading global biotech company focused on rare diseases, announces unaudited results for the three...

Genetics Update: Q1 in Review

With Q1 2018 officially in the books, here the Investing News Network takes a look back at what some of...

Shire Receives FDA Approval for Rare Disease Drug, Share Price Rises

Shire has received another FDA approval with the second approval for Vonvendi, a treatment for perioperative bleeding management in adults...

Shire: FDA APPROVES VONVENDI

Shire (LSE: SHP, NASDAQ: SHPG), the global  biotechnology leader in rare disease, today announced the U.S. Food and Drug Administration...

Shire plc : Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Shire (LSE: SHP, NASDAQ: SHPG) the leading global biotechnology company focused on rare diseases announces today that it has entered...